Mitoguazone

• Description:

  Mitoguazone (Methyl-GAG) is a selective S-adenosyl-methionine decarboxylase inhibitor that penetrates the blood-brain barrier and disrupts polyamine biosynthesis. Mitoguazone is a synthetic polycarbonyl derivative with anti-tumor activity that inhibits the integration of HIV DNA into cellular DNA in monocytes and macrophages, inducing apoptosis. Mitoguazone can be used to prevent acute leukemia, Hodgkin lymphoma and non-Hodgkin lymphoma.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  184.2

• Molecular Formula:

  C5H12N8

• Notes:

  Research use only, not for human use.

• Receptor:

  Apoptosis | HIV Protease

• CAS Number:

  459-86-9